Filing Details
- Accession Number:
- 0001161697-24-000445
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-13 17:44:37
- Reporting Period:
- 2024-11-11
- Accepted Time:
- 2024-11-13 17:44:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 929985 | J Patrick Mcenany | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-11-11 | 230,000 | $4.01 | 4,708,169 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-11-11 | 230,000 | $23.55 | 4,478,169 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-11-12 | 70,000 | $4.01 | 4,548,169 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-11-12 | 70,000 | $23.42 | 4,478,169 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-11-12 | 192,000 | $3.54 | 4,670,169 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-11-12 | 192,000 | $23.20 | 4,478,169 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2024-11-11 | 230,000 | $0.00 | 230,000 | $4.01 |
| Common Stock | Options to purchase common stock | Disposition | 2024-11-12 | 70,000 | $0.00 | 70,000 | $4.01 |
| Common Stock | Options to purchase common stock | Disposition | 2024-11-12 | 192,000 | $0.00 | 192,000 | $3.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,362,745 | 2025-01-02 | No | 4 | M | Direct | |
| 2,292,745 | 2025-01-02 | No | 4 | M | Direct | |
| 2,100,745 | 2025-05-29 | No | 4 | M | Direct |
Footnotes
- Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.29 to $23.873 per share.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.30 to $23.50 per share.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.03 to $23.48 per share.
- Options vested in three equal tranches on January 2, 2019, 2020 and 2021.
- Options vested in three equal tranches on May 29, 2019, 2020 and 2021.
Billionaire Hedge Funds
